Patrick M. Moriarty, MD, is a Professor in the Department of Internal Medicine at the University of Kansas Medical Center in Kansas City, Kansas. He is the Director of Clinical Pharmacology and the Atherosclerosis/ Lipid Apheresis Center. He earned his MD in Medicine and Surgery at the University of Rome School of Medicine and Surgery in Italy and completed his residency in Internal Medicine and training in Clinical Pharmacology at the University of Kansas Medical Center.
Dr. Moriarty is a fellow of the American College of Physicians, the American College of Cardiology, and the National Lipid Association. He is this year's president of the International Society for Apheresis and serves as a manuscript reviewer for multiple scientific journals and is the associate editor for The Journal of Clinical Apheresis and Clinical Lipidology. He has authored or co-authored over 100 articles, abstracts and chapters in peer review journals.
His research activities include atherosclerosis, Lipid-Apheresis, vascular inflammation and hemorheology. He has participated in over 100 clinical trials related to dyslipidemia, obesity, hypertension, and diabetes. His clinical activities involve the treatment and diagnosis of atherosclerosis and cardiovascular disease. The Kansas University Lipid-apheresis center, for the treatment of Familial Hypercholesterolemia, is one of the largest in North America.